Reply to correspondence on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy"
Clin Mol Hepatol
.
2024 Oct;30(4):1050-1052.
doi: 10.3350/cmh.2024.0546.
Epub 2024 Jul 12.
Authors
Seren M Gedallovich
1
,
Paul Y Kwo
1
Affiliation
1
Division of Gastroenterology and Hepatology, Stanford University Medical School, Stanford, CA, USA.
PMID:
38993076
PMCID:
PMC11540377
DOI:
10.3350/cmh.2024.0546
No abstract available
Keywords:
DAA; Epigenetic; HCV; Hepatocellular cancer.